CDC’s 2022 Clinical Practice Guideline for Prescribing Opioids for Pain (Web Based) - WB4701
This module provides an overview of the 2022 Clinical Practice Guideline recommendations intended for clinicians providing pain care, including those prescribing opioids for outpatients with acute, subacute, and chronic pain.
Category
  • CDC Clinical Practice Guideline for Prescribing Opioids for Pain
  • Pain Management: Opioid(s)
  • Prescribing: Opioid(s)
Format
  • Self-study / Enduring
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
Cost $0.00
Optimizing Patient Care Through Telehealth: Pain Management and Opioids, Balancing Risks and Benefits
This series of videos is aimed at helping you engage in successful pain management telehealth visits with your patients. Clinicians may have had little to no training on the communication and clinical skills needed for telehealth patient encounters.
Category
  • Pain Management
  • Pain Management: Opioid(s)
  • Telemedicine
Format
  • Self-study / Enduring
Credits
  • 1.00 AAPA Category I CME
Cost $0.00
Preventive Medicine Grand Rounds - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain - October 4, 2023 (Web on Demand) - WD4441-100423
Category
  • CDC Clinical Practice Guideline for Prescribing Opioids for Pain
  • Pain Management: Opioid(s)
  • Prescribing: Opioid(s)
Format
  • Self-study / Enduring
Credits
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 ANCC
Cost $0.00
Bupe...There it is! Part I - Prescribing Basics | Palliative Care Educational Series (RECORDING)
In this recorded Palliative Care Educational Series presentation, palliative care and addiction medicine specialist Dr. Janet Ho provides a comprehensive overview on the use of buprenorphine, a partial opioid agonist, for pain management and treatment of opioid use disorder. Dr.
Category
  • Palliative Care
  • Buprenorphine
  • Opioid Use Disorder (OUD)
  • Pain Management
Format
  • Self-study / Enduring
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $0.00
Real Psychiatry: An Update on ADHD & Substance Use Disorder for Advanced Practice Professionals
In recent years, there have both been many challenges and advancements in the treatment of ADHD and substance use disorder (SUD) that significantly influence the way advanced practice professionals navigate day-to-day practice.
Category
  • Substance Use Disorder (SUD)
Format
  • Self-study / Enduring
Credits
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
Cost $0.00
ORN Fall 2023 - The Evolution of Buprenorphine: Prescribing practices and efforts to increase MOUD access
This talk will describe the distribution of buprenorphine patient caseloads for clinicians prescribing formulations of buprenorphine indicated to treat opioid use disorder, how those caseloads evolve over time, and factors associated higher-volume buprenorphine prescribers.
Category
  • Buprenorphine
  • Opioid Use Disorder (OUD)
Format
  • Self-study / Enduring
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 AOA Category 1-A
Cost $0.00
Buprenorphine Mini Course: Building on Federal Prescribing Guidance
This 2-hour mini course for medical providers, clinicians, and students reviews prescribing buprenorphine to patients with opioid use disorder and is presented by ASAM in collaboration with the American Medical Association (AMA) and Shatterproof.
Category
  • Buprenorphine
Format
  • Self-study / Enduring
Credits
  • 2.00 AMA PRA Category 1 Credit™
Cost $0.00
Embracing the Journey: End-of-Life Care Planning and Palliative Care
Our population is aging and so are our patients. Learn how to address advance care planning issues such as long term care planning, pain management, and end of life documentation that are necessary in caring for your older patients.  Dr.
Category
  • End of Life Care
  • Palliative Care
  • Pharmacology
Format
  • Self-study / Enduring
Credits
  • 1.00 AANP Contact Hours
  • 0.25 AANP Pharmacology Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
Cost $0.00
COLORADO CONSORTIUM FOR PRESCRIPTION DRUG ABUSE PREVENTION
Category
  • Drug Diversion
  • State Mandated Training
Format
  • Self-study / Enduring
Credits
  • 3.50 AMA PRA Category 1 Credit™
Cost $0.00
Therapeutic Use of KASPER and Urine Drug Screening and Testing in Clinical Practice
Needs Statement
Category
Format
  • Self-study / Enduring
Credits
  • 0.75 AMA PRA Category 1 Credit™
Cost $0.00

Pages